Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Summer;16(3):1147-1154.

Interfering With Lipid Raft Association: A Mechanism to Control Influenza Virus Infection By Sambucus Nigra

Affiliations

Interfering With Lipid Raft Association: A Mechanism to Control Influenza Virus Infection By Sambucus Nigra

Shahla Shahsavandi et al. Iran J Pharm Res. 2017 Summer.

Abstract

Sambucus nigra (elder) are broadly used species to treat microbial infections. The potential antiviral activity and mechanism action of elder fruit (EF) in human epithelium cell (A549) cultures infected with H9N2 influenza virus were determined. The effect of various concentrations of EF on influenza virus replication was examined by using virus titration, quantitative real time RT-PCR, fusion and lipid raft assays following two treatment procedures: A) pre-treated H9N2 virus with each concentration of EF extract and transfection of A549 cell cultures, and B) each concentrations of EF was added to H9N2 virus infected-cell cultures following virus adsorption. In both treatments with lower doses of EF increased viral titer as well as synthesized viral nucleoprotein as indicating the herb had no inhibitory effects on virus replication. In (B) trial with higher doses, 40 and 80 μg/mL of EF, a significant decrease in virus titer and viral protein synthesis were shown in EF treated cells indicating the herb affect either entry of viruses or inhibition virus particle release. The results suggest that EF treatment of the influenza virus infected-human epithelial cells may involve in lipid raft association which function as platform for formation of viral membrane fusion and budding. Differencesin treatment time and dose of EF extract in infected cells with influenza virus have a marked effect on the efficacy of the herb.

Keywords: Antiviral activity; Hemagglutinin; Influenza virus; Lipid raft; Sambucus nigra.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Microscopic analyses of H9N2 influenza virus infected A549 cells after 48 h incubation with different concentrations of Sambucus nigra (EF) extract (100X magnification).the influenza-virus infected A549 cells became rounded and eventually detached in (A) treatment with 40 and 80μg/mL of EF in compared with the uninfected cells (mock), while the CPE was not observed in (B) trial
Figure 2
Figure 2
Inhibition of H9N2 influenza virus replication in the presence of different concentrations of Sambucus nigra (EF) extract was determined. The titer of virus in A549 supernatants was assayed by TCID50 in trials (A) and (B) with 40 and 80 μg/mL of EF compared to the virus-infected and EF-untreated cells (mock
Figure 3
Figure 3
Triton X-100 solubilization analysis of A549cells infected with H9N2influenza virus in pre- and post treatments of Sambucus nigra (EF). Equivalent aliquots from soluble material (S) and insoluble (I) fractions of 80 mg/mL of EF in trials (A) and (B) were subjected to SDS-PAGE. Then viral HA and NP were detected by Western blot using specific antibodies. HA incorporated into lipid raft during virus attachment to the cell membrane. In post treatment with the higher dose of EF, the solubility of HA was affected due to the disruption of lipid raft, whereas the solubility of the protein remained unaffected in control (C). The NP floated to the top fraction in (A) treatment

Similar articles

Cited by

References

    1. Butt AM, Siddique S, Idrees M, Tong Y. Avian influenza A (H9N2): computational molecular analysis and phylogenetic characterization of viral surface proteins isolated between 1997 and 2009 from the human population. Virol.J. . 2010;7:319. - PMC - PubMed
    1. Butt KM, Smith GJD, Chen H, Zhang LJ, Leung YH, Xu KM, Lim W, Webster RG, Yuen KY, Peiris JS, Guan Y. Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J. Clin. Microbiol. . 2005;43:5760–7. - PMC - PubMed
    1. Moscona A. Medical management of influenza infection. Annu. Rev. Med. . 2008;59:397–413. - PubMed
    1. Ong AK, Hayden FG, Enders JF. Antivirals for influenza. J. Infec. Dis. . 2007;196:181–90. - PubMed
    1. Boltz DA, Aldridge JR, Webster RG, Govorkova EA. Drugs in development for influenza. Drugs . 2010;70:1349–62. - PMC - PubMed

LinkOut - more resources